3) Curriculum e Pubblicazioni - Autoprelievo Test HPV

Curriculum Vitae

Dott. Guido Nicolò,

Nato a Venezia 19-09-1941. Coniugato con un figlio, laureato in Medicina e Chirurgia e specialista in oftalmologia.

1960 Maturita’ classica presso l’Istituto B. Arecco di Genova, con votazione media 7/10

1966 Laurea in Medicina e Chirurgia presso l’Universita’ di Genova con la votazione di 110/110,

medaglia d’argento

1966-1967 Training in Immunopatologia presso l’Istituto di Medicina del Lavoro dell’Universita’ di

Genova diretto dal Prof. B. Pernis e specializzazione i medicina del lavoro presso

l’Università di Genova

1967-1969 Assistente presso il Dipartimento di Patologia dell’Ospedale Maggiore di Bergamo

1969-1979 Assistente presso il Dipartimento di Patologia dell’Ospedale San Martino di Genova

acquisendo esperienza nella diagnosi citologica dei tumori, in particolare della

cervice uterina

1970 Specializzazione in Anatomia Patologica

1974 Specializzazione in in Oncologia presso l’Universita’ di Genova

1980 Direttore del Servizio di Anatomia e Cito-Istologia Patologica dell’Istituto Nazionale per la

Ricerca sul Cancro e titolare dell’insegnamento di Patologia dei tumori presso la Scuola di

Specializzazione in Oncologia dell’Universita’ di Genova

1983 Esperienza presso la Minneapolis University (Minnesota, U.S.) nel Surgical Pathology

Department diretto dal Prof. J. Rosai

1984-1987 Corsi di Aggiornamento in citologia e istologia diagnostica per patologi italiani.

Co-direttore, Prof. G. Pedio (Zurich University Pathology Department)

1987 Componente ufficiale del Pathology Group dell’OECI

1987-1991 Coordinatore di un progetto sulla produzione di anticorpi monoclonali utilizzabili in

citofluorimetria

1991-1995 Partecipante al progetto della Comunita’ Europea Catai (Courses Advanced Technology Image

Analysis), per la realizzazione di una rete di videoconsulto tra otto stati europei.

1996-1999 Consulente patologo per BreakIT (Breast Cancer Pathologist Information Kit, using on-line

and off-line information technologies)

1998 Responsabile scientifico del Progetto ” European Courses of Oncopathology and

telepathology” – 5 Corsi Internazionali di Aggiornamento in Patologia mediante supporto

Telematico con partecipazione di oltre 100 patologi Europei.

1999-2001 Responsabile scientifico del Progetto “Telematic Network between National Cancer Institute of

Genoa , Center Universitaire-Hospitalier (C.H.U.) of Nice, and Nearborders Countries”( ASL1,

“Imperiese” e ASL2 “Savonese”, con un finanziamento di 1600 milioni. Il progetto aveva lo

scopo di realizzare due reti di telemedicina per consultazione nel campo della patologia

microscopica (prima fase realizzata) e nel campo della oftalmologia (secona fase non

realizzata) per ridurre il flusso di pazienti dal ponente ligure verso i Centri di Nizza e

di Genova.

2001-2003 Consulente patologo di progetto europeo per la costruzione di un prototipo di

microscopio digitalizzato, da inserire nei flussi di informazione delle

strutture sanitarie con la partecipazione di ditte Franco Tedesche (Siemens ecc.).

2002-2004 Coordinatore dei patologi degli Istituti Europei del Cancro (60) con il progetto di

formulare proposte per la standardizzazione dei referti di patologia oncologica.

2003 Partecipante con gli altri 6 Istituti Italiani per lo Studio e la Cura dei tumori alla realizzazione

di una rete Telematica, per la consultazione rapida su casi di difficile interpretazione

microscopica, mediante la metodologia del vetrino virtuale.

Pubblicazioni

)      HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients.
Del Mastro L, Bruzzi P, Nicolò G, Cavazzini G, Contu A, D’Amico M, Lavarello A, Testore F, Castagneto B, Aitini E, Perdelli L, Bighin C, Rosso R, Venturini M.Br J Cancer. 2005 Jul 11;93(1):7-14. doi: 10.1038/sj.bjc.6602660.PMID: 15970926 Free PMC article. Clinical Trial.

2)      Multiple bilateral choroidal metastatic tumors from a small-cell neuroendocrine carcinoma of unknown primary site.
Nicolò M, Piccolino FC, Ghiglione D, Nicolò G, Calabria G. Eur J Ophthalmol. 2005 Jan-Feb;15(1):148-52. doi: 10.1177/112067210501500126.PMID: 15751257

3)      Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
Gipponi M, Di Somma C, Peressini A, Solari N, Gliori S, Nicolo G, Schenone F, Queirolo P, Sertoli MR, Cafiero F.J Surg Oncol. 2004 Mar;85(3):133-40. doi: 10.1002/jso.20026.PMID: 14991885 Review.

4)      Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022.PMID: 14991881 Review.

5)      Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.
Ghiorzo P, Villaggio B, Sementa AR, Hansson J, Platz A, Nicoló G, Spina B, Canepa M, Palmer JM, Hayward NK, Bianchi-Scarrà G.Hum Pathol. 2004 Jan;35(1):25-33. doi: 10.1016/j.humpath.2003.08.017.PMID: 14745721

6)      Trilucent breast implants: five years’ experience from an Italian perspective.
Cicchetti S, Spina B, Nicolò G, Santi PL.Ann Plast Surg. 2003 Sep;51(3):229-35. doi: 10.1097/01.SAP.0000067965.94072.59.PMID: 12966232

7)      A decision support system to detect morphologic changes of chromatin arrangement in normal-appearing cells.
Sacile R, Montaldo E, Ruggiero C, Nieburgs HE, Nicolò G.IEEE Trans Nanobioscience. 2003 Jun;2(2):118-23. doi: 10.1109/tnb.2003.813939.PMID: 15382668 Clinical Trial.

8)      Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer.
Boccardo F, Rubagotti A, Carmignani G, Romagnoli A, Nicolò G, Barboro P, Parodi S, Patrone E, Balbi C.Prostate. 2003 Jun 1;55(4):259-64. doi: 10.1002/pros.10248.PMID: 12712405

9)      Analysis of HLA-G expression in breast cancer tissues.
Palmisano GL, Pistillo MP, Fardin P, Capanni P, Nicolò G, Salvi S, Spina B, Pasciucco G, Ferrara GB.Hum Immunol. 2002 Nov;63(11):969-76. doi: 10.1016/s0198-8859(02)00642-0.PMID: 12392849

10) Pleomorphic adenocarcinoma of the ciliary epithelium: a clinicopathological, immunohistochemical, ultrastructural, DNA-ploidy and comparative genomic hybridization analysis of an unusual case.
Nicolò M, Nicolò G, Zingirian M.Eur J Ophthalmol. 2002 Jul-Aug;12(4):319-23. doi: 10.1177/112067210201200412.PMID: 12220004

11) The role of sentinel lymph node biopsy in patients with stage I/II cutaneous melanoma. The clinical experience at the National Cancer Research Institute of Genoa, Italy.
Cafiero F, Gipponi M, Di Somma C, Solari N, Peressini A, Gliori S, Bassetti C, Spina B, Nicolò G, Schenone F, Castagnola F, Queirolo P, Sertoli MR.Tumori. 2002 May-Jun;88(3):S55-6. doi: 10.1177/030089160208800347.PMID: 12369556 No abstract available.

12) Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.
Sirchia SM, Ren M, Pili R, Sironi E, Somenzi G, Ghidoni R, Toma S, Nicolò G, Sacchi N.Cancer Res. 2002 May 1;62(9):2455-61.PMID: 11980632 Free article.

13) Solitary fibrous tumor of the inguinal region: a clinicopathological, light-microscopic, immunohistochemical, electron microscopic and flow-cytometric DNA study.
Cafiero F, Gipponi M, Peressini A, Barabino P, Queirolo P, Nicolò M, Solari N, Nicolò G.Anticancer Res. 2001 Nov-Dec;21(6A):4091-4.PMID: 11911298

14) Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases.
Pugliese V, Pujic N, Saccomanno S, Gatteschi B, Pera C, Aste H, Ferrara GB, Nicolò G.Gastrointest Endosc. 2001 Nov;54(5):595-9. doi: 10.1067/mge.2001.119220.PMID: 11677475

15) Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.Cancer. 2001 Oct 1;92(7):1896-904.PMID: 11745263

16) Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients.
Canavese G, Gipponi M, Catturich A, Vecchio C, Tomei D, Nicoló G, Carli F, Spina B, Bonelli L, Villa G, Buffoni F, Bianchi P, Agnese A, Mariani G.J Surg Oncol. 2001 Jun;77(2):81-7; discussion 88. doi: 10.1002/jso.1074.PMID: 11398158

17) [The STF Project: Female Tumor Screening].
Branca M, Rossi E, Cedri S, Migliore G, Midulla C, De Lorio P, Giovagnoli MR, Carraro C, Vecchione A, Bonelli L, Nicolò G, Gustavino C, Ferreri M, Barizzone D, Santi L, Morosini PL.Pathologica. 2001 Feb;93(1):20-7.PMID: 11294015 Italian.

18) Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL, Pistillo MP, Capanni P, Pera C, Nicolò G, Salvi S, Perdelli L, Pasciucco G, Ferrara GB.Hum Immunol. 2001 Feb;62(2):133-9. doi: 10.1016/s0198-8859(00)00241-x.PMID: 11182222

19) Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.
Toma S, Raffo P, Nicolo G, Canavese G, Margallo E, Vecchio C, Dastoli G, Iacona I, Regazzi-Bonora M.Int J Oncol. 2000 Nov;17(5):991-1000. doi: 10.3892/ijo.17.5.991.PMID: 11029503 Clinical Trial.

20) Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
Decensi A, Torrisi R, Bruno S, Costantini M, Curotto A, Nicolò G, Malcangi B, Baglietto L, Bruttini GP, Gatteschi B, Rondanina G, Varaldo M, Perloff M, Malone WF, Bruzzi P.Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1071-8.PMID: 11045790 Clinical Trial.

21) Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer.
Alberti I, Barboro P, Barbesino M, Sanna P, Pisciotta L, Parodi S, Nicolò G, Boccardo F, Galli S, Patrone E, Balbi C.J Cell Biochem. 2000 Sep 7;79(3):471-85.PMID: 10972984

22) Localization of the sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye and intraoperative gamma probe.
Villa G, Gipponi M, Buffoni F, Vecchio C, Bianchi P, Agnese G, Di Somma C, Catturich A, Rosato F, Tomei D, Nicolò G, Badellino F, Mariani G, Canavese G.Tumori. 2000 Jul-Aug;86(4):297-9. doi: 10.1177/030089160008600408.PMID: 11016707

23) Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue-dye, and intraoperative gamma-probe.
Mariani G, Villa G, Gipponi M, Bianchi P, Buffoni F, Agnese G, Vecchio C, Tomei D, Carli F, Nicolò G, Canavese G.Cancer Biother Radiopharm. 2000 0 Jun;15(3):245-52. doi: 10.1089/108497800414338.PMID: 10941531

24) Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients.
Canavese G, Gipponi M, Catturich A, Di Somma C, Vecchio C, Rosato F, Tomei D, Nicolò G, Carli F, Villa G, Agnese G, Bianchi P, Buffoni F, Mariani G, Badellino F.J Surg Oncol. 2000 May;74(1):69-74. doi: 10.1002/1096-9098(200005)74:1<69::aid-jso15>3.0.co;2-z.PMID: 10861613 Clinical Trial.

25) Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
Canavese G, Gipponi M, Catturich A, Di Somma C, Vecchio C, Rosato F, Percivale P, Moresco L, Nicolò G, Spina B, Villa G, Bianchi P, Badellino F.J Surg Oncol. 2000 May;74(1):61-8. doi: 10.1002/1096-9098(200005)74:1<61::aid-jso14>3.0.co;2-9.PMID: 10861612 Clinical Trial.

26) Biochemical analysis of HLA class I subunits expression in breast cancer tissues.
Pistillo MP, Nicolò G, Salvi S, Capanni P, Perdelli L, Pasciucco G, Ferrara GB.Hum Immunol. 2000 Apr;61(4):397-407. doi: 10.1016/s0198-8859(99)00179-2.PMID: 10715517

27) Selective lymph node dissection in patients with intermediate thickness melanoma: our experience.
Cafiero F, Peressini A, Percivale PL, Rainero ML, Faggioni M, Gipponi M, Queirolo P, Nicolo G, Bertoglio S.Anticancer Res. 2000 Jan-Feb;20(1B):497-500.PMID: 10769712

28) Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial.
Bruno S, Torrisi R, Costantini M, Baglietto L, Fontana V, Gatteschi B, Melioli G, Nicolo G, Curotto A, Malcangi B, Bruttini GP, Varaldo M, Bruzzi P, Decensi A.J Cell Biochem. 1999 Dec;76(2):311-21. doi: 10.1002/(sici)1097-4644(20000201)76:2<311::aid-jcb14>3.0.co;2-a.PMID: 10618647 Clinical Trial.

29) Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions.
Ciotti P, Pesce GP, Cafiero F, Rainero ML, Sementa A, Nicolò G, Mela GS, Bagnasco M, Santi PL, Bianchi-Scarrà G.Melanoma Res. 1999 Jun;9(3):253-60. doi: 10.1097/00008390-199906000-00007.PMID: 10465581

30) Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody.
Carnemolla B, Castellani P, Ponassi M, Borsi L, Urbini S, Nicolo G, Dorcaratto A, Viale G, Winter G, Neri D, Zardi L.Am J Pathol. 1999 May;154(5):1345-52. doi: 10.1016/S0002-9440(10)65388-6.PMID: 10329587 Free PMC article.

31) Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors.
Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, Michiels JF, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C.Genes Chromosomes Cancer. 1999 Jan;24(1):30-41.PMID: 9892106

32) Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: a combined approach with vital blue dye lymphatic mapping and radioguided surgery.
Canavese G, Gipponi M, Catturich A, Di Somma C, Vecchio C, Rosato F, Tomei D, Cafiero F, Moresco L, Nicolò G, Carli F, Villa G, Buffoni F, Badellino F.Semin Surg Oncol. 1998 Dec;15(4):272-7. doi: 10.1002/(sici)1098-2388(199812)15:4<272::aid-ssu17>3.0.co;2-i.PMID: 9829386 Clinical Trial.

33) Novel germline APC variants in patients with multiple adenomas.
Pedemonte S, Sciallero S, Gismondi V, Stagnaro P, Biticchi R, Haeouaine A, Bonelli L, Nicolŏ G, Groden J, Bruzzi P, Aste H, Varesco L.Genes Chromosomes Cancer. 1998 Aug;22(4):257-67. doi:

34) Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients.
Bertelli G, Venturini M, Del Mastro L, Garrone O, Cosso M, Gustavino C, Cusimano E, Guido T, Nicolò G, Rosso R.Breast Cancer Res Treat. 1998 Jan;47(1):41-6. doi: 10.1023/a:1005820115535.PMID: 9493974

35) Isolation and characterization of human tumor-derived capillary endothelial cells: role of oncofetal fibronectin.
Alessandri G, Chirivi RG, Castellani P, Nicoló G, Giavazzi R, Zardi L.Lab Invest. 1998 Jan;78(1):127-8.PMID: 9461129 No abstract available.

36) Breast intraductal masses: US-guided fine-needle aspiration after galactography.
Sardanelli F, Imperiale A, Zandrino F, Calabrese M, Bonifacio A, Canavese G, Nicolo G. Radiology. 1997 Jul;204(1):143-8. doi: 10.1148/radiology.204.1.9205236.PMID: 9205236

37) Cytofluorometric and cytogenetic evaluation of renal cell carcinoma: correlations with the clinical course.
Bartoletti R, Selli C, Nicolò G, Margallo E, Amorosi A.Urol Int. 1997;58(1):1-7. doi: 10.1159/000282935.PMID: 9058512

38) Differential nuclear matrix-intermediate filament expression in human prostate cancer in respect to benign prostatic hyperplasia.
Alberti I, Parodi S, Barboro P, Sanna P, Nicolò G, Allera C, Patrone E, Galli S, Balbi C.Cancer Lett. 1996 Dec 3;109(1-2):193-8. doi: 10.1016/s0304-3835(96)04444-8.PMID: 9020920

39) Age-related changes in neutral lipid content of Paramecium primaurelia as revealed by nile red.
Ramoino P, Margallo E, Nicolò G.J Lipid Res. 1996 Jun;37(6):1207-12.PMID: 8808755 Free article.

40) A study on macronuclear chromatin structure in Colpoda inflata (Protozoa, Ciliophora) by means of image analysis.
Corrado MU, Pelli P, Chessa MG, Margallo E, Lattes A, Nicolò G.Eur J Histochem. 1996;40(3):181-8.PMID: 8922946

41) Cytofluorometric evaluation of nuclear DNA content distribution in renal neoplasms treated by conservative surgery.
Selli C, Nicolò G, Margallo E, Bartoletti R, Amorosi A.Urol Int. 1996;57(3):151-7. doi: 10.1159/000282901.PMID: 8912443

42) Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study.
Pugliese V, Conio M, Nicolò G, Saccomanno S, Gatteschi B.Gastrointest Endosc. 1995 Dec;42(6):520-6. doi: 10.1016/s0016-5107(95)70004-8.PMID: 8674921

43) Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast.
Torrisi R, Zanardi S, Pensa F, Valenti G, De Franchis V, Nicolo G, Barreca A, Minuto F, Boccardo F.Breast Cancer Res Treat. 1995 Mar;33(3):219-24. doi: 10.1007/BF00665946.PMID: 7749149

44) Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens.
Ciotti P, Rainero ML, Nicolò G, Spina B, Garrè C, Casabona F, Santi PL, Bianchi-Scarrà G.Melanoma Res. 1995 Feb;5(1):41-7. doi: 10.1097/00008390-199502000-00005.PMID: 7734955

45) The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.
Castellani P, Viale G, Dorcaratto A, Nicolo G, Kaczmarek J, Querze G, Zardi L.Int J Cancer. 1994 Dec 1;59(5):612-8. doi: 10.1002/ijc.2910590507.PMID: 7525495

46) Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues.
Kaczmarek J, Castellani P, Nicolo G, Spina B, Allemanni G, Zardi L.Int J Cancer. 1994 Oct 1;59(1):11-6. doi: 10.1002/ijc.2910590104.PMID: 7927891

47) Supernumerary ring chromosomes containing chromosome 17 sequences. A specific feature of dermatofibrosarcoma protuberans?
Pedeutour F, Coindre JM, Sozzi G, Nicolo G, Leroux A, Toma S, Miozzo M, Bouchot C, Hecht F, Ayraud N, et al.Cancer Genet Cytogenet. 1994 Aug;76(1):1-9. doi: 10.1016/0165-4608(94)90060-4.PMID: 8076341

48) Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines.
Toma S, Monteghirfo S, Tasso P, Nicolò G, Spadini N, Palumbo R, Molina F.Cancer Lett. 1994 Jul 29;82(2):209-16. doi: 10.1016/0304-3835(94)90014-0.PMID: 8050093

49) Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP, Margallo E, Margiocco M, Paganuzzi M, Marroni P, Costanzi B, Gatteschi B, Tanara G, Spina B, Nicolò G.Oncology. 1994 Jul-Aug;51(4):329-33. doi: 10.1159/000227359.PMID: 8208515

50) Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma.
Pedeutour F, Suijkerbuijk RF, Forus A, Van Gaal J, Van de Klundert W, Coindre JM, Nicolo G, Collin F, Van Haelst U, Huffermann K, et al.Genes Chromosomes Cancer. 1994 Jun;10(2):85-94. doi: 10.1002/gcc.2870100203.PMID: 7520271

51) Epidemiology and etiology of “autonomous” nonspecific duodenitis.
Cheli R, Nicoló G, Bovero E, Salvi S, Testino G, De Iaco F.J Clin Gastroenterol. 1994 Apr;18(3):200-5. doi: 10.1097/00004836-199404000-00005.PMID: 8034914

52) Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma.
Del Mastro L, Garrone O, Guenzi M, Cafiero F, Nicolò G, Rosso R, Venturini M.Ann Oncol. 1994 Feb;5(2):163-5. doi: 10.1093/oxfordjournals.annonc.a058770.PMID: 8186160 Free article. Review.

53) Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point.
Decensi A, Bruno S, Costantini M, Torrisi R, Curotto A, Gatteschi B, Nicolò G, Polizzi A, Perloff M, Malone WF, et al.J Natl Cancer Inst. 1994 Jan 19;86(2):138-40. doi: 10.1093/jnci/86.2.138.PMID: 8271297 Clinical Trial. No abstract available.

54) Primary gastric lymphoma.
Secco GB, Fardelli R, Campora E, Munizzi F, Aste H, Nicolò G.J Surg Oncol. 1993 Nov;54(3):157-62. doi: 10.1002/jso.2930540306.PMID: 8412170

55) Ring chromosomes in dermatofibrosarcoma protuberans contain chromosome 17 sequences: fluorescence in situ hybridization.
Pedeutour F, Coindre JM, Nicolo G, Bouchot C, Ayraud N, Carel CT.Cancer Genet Cytogenet. 1993 Jun;67(2):149. doi: 10.1016/0165-4608(93)90171-h.PMID: 8330274 No abstract available

56) Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
Fusco V, Ardizzoni A, Merlo F, Cinquegrana A, Faravelli B, De Palma M, Chessa L, Nicolò G, Serra M, Capaccio A, et al.Anticancer Res. 1993 May-Jun;13(3):683-9.PMID: 8317897

57) Localization of the alpha 3 beta 1 integrin in some common epithelial tumors of the ovary and in normal equivalents.
Bartolazzi A, Kaczmarek J, Nicoló G, Risso AM, Tarone G, Rossino P, Defilippi P, Castellani P.Anticancer Res. 1993 Jan-Feb;13(1):1-11.PMID: 8476198

58) Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues.
Borsi L, Carnemolla B, Nicolò G, Spina B, Tanara G, Zardi L.Int J Cancer. 1992 Nov 11;52(5):688-92. doi: 10.1002/ijc.2910520504.PMID: 1385335

59) Progressive 13-cis-retinoic acid dosage in the treatment of oral leukoplakia.
Toma S, Mangiante PE, Margarino G, Nicolo G, Palumbo R.Eur J Cancer B Oral Oncol. 1992 Oct;28B(2):121-3. doi: 10.1016/0964-1955(92)90039-4.PMID: 1306729

60) [Efficacy of the combination of nicardipine-enalapril and atenolol in severe hypertension secondary to chronic renal disease].
Melina D, Guerrera G, Santoliquido A, Guerrera C, Musumeci V, Nicolò G, Cataldo R.Ann Cardiol Angeiol (Paris). 1992 Jun;41(6):351-3.PMID: 1444161 French.

61) Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma.
Alama A, Merlo F, Chiara S, Muttini MP, Guido T, Nicolò G, Conte PF, Ragni N.Eur J Cancer. 1992;28A(6-7):1079-80. doi: 10.1016/0959-8049(92)90461-a.PMID: 1627379

62) Treatment of oral leukoplakia with beta-carotene.
Toma S, Benso S, Albanese E, Palumbo R, Cantoni E, Nicolò G, Mangiante P.Oncology. 1992;49(2):77-81. doi: 10.1159/000227016.PMID: 1574255 Clinical Trial.

63) In vitro effects of beta-carotene on human oral keratinocytes from precancerous lesions and squamous carcinoma.
Toma S, Albanese E, Palumbo R, Nicoló G, Morerio C, Magiante PE, Bonatti S, Cancedda R, Santi L.Anticancer Drugs. 1991 Dec;2(6):581-9. doi: 10.1097/00001813-199112000-00009.PMID: 1806035

64) Univariate and multivariate analyses of the relationship between adenocarcinoma and solitary and multiple adenomas in colorectal adenoma patients.
Gatteschi B, Costantini M, Bruzzi P, Merlo F, Torcoli R, Nicolo G.Int J Cancer. 1991 Oct 21;49(4):509-12. doi: 10.1002/ijc.2910490406.PMID: 1917150

65) Predictive value of some clinical and pathological parameters on upper level axillary lymph node involvement in breast cancer.
Toma S, Leonessa F, Romanini A, Badellino F, Bonassi S, Nicolo G, Rosso R.Anticancer Res. 1991 Jul-Aug;11(4):1439-43.PMID: 1746901

66) Cellular and Molecular Characterization of Two Cases of Castleman’s Disease, Plasma Cell Variant.
Roncella S, Di Celle PF, D’amore ES, Casoli C, Cutrona G, Muzzulini C, Quaini F, Nicolo G, Foa R, Pistoia V.Leuk Lymphoma. 1991;5(5-6):391-6. doi: 10.3109/10428199109067634.PMID: 27463351

67) Invasive activity, spreading on and chemotactic response to laminin are properties of high but not low metastatic mouse osteosarcoma cells.
Aresu O, Nicolò G, Allavena G, Melchiori A, Schmidt J, Kopp JB, d’Amore E, Chader GJ, Albini A.Invasion Metastasis. 1991;11(1):2-13.PMID: 2061001

68) Endocervical metastases secondary to breast carcinoma. A case report.
Campora E, Serra GE, Nicolò G, Gatteschi B, Rosso R.Eur J Gynaecol Oncol. 1991;12(2):103-6.PMID: 2055223

69) Perioperative radioimmunolocalization of colorectal cancer by radiolabeled monoclonal antibodies.
Badellino F, Percivale P, Meszaros P, Gipponi M, Bartolomeo S, Nicolo G, Spina B, Schenone F, Bertoglio S.J Surg Oncol Suppl. 1991;2:86-91. doi: 10.1002/jso.2930480520.PMID: 1892537 No abstract available.

70) Identification of breast cyst subpopulations: biochemical and morphological features.
Zanardi S, Valenti G, Torrisi R, Maisto L, Nicolò G, Barreca A, Minuto F, Boccardo F.Cancer Detect Prev. 1991;15(4):273-6.PMID: 1838953

71) Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer.
Nicolò G, Salvi S, Oliveri G, Borsi L, Castellani P, Zardi L.Cell Differ Dev. 1990 Dec 2;32(3):401-8. doi: 10.1016/0922-3371(90)90056-3.PMID: 1711919 Review.

72) Manipulation of the growth rate of human breast cancer cells by antiandrogen followed by chemotherapy.
Alama A, Miglietta L, Favoni RE, Barbieri F, Ravera F, Fazzuoli L, Nicolo G, Nicolin A.Anticancer Res. 1990 May-Jun;10(3):853-8.PMID: 2142397

73) Role of diagnostic lymphnode biopsies in 56 anti-HIV positive patients.
Moresco L, Gipponi M, CaFiero F, Badellino F, Pagano G, Alessandrini A, Nicolo G.Cancer Detect Prev. 1990;14(3):353-7.PMID: 2386972
74) Epidermal growth factor in breast cyst fluids. Relationships with the morphology of cyst epithelium.
Boccardo F, Zanardi S, Valenti G, Cannata D, Maisto L, Nicoló G, Barreca A, Del Monte P, Minuto F.Ann N Y Acad Sci. 1990;586:137-42. doi: 10.1111/j.1749-6632.1990.tb17800.x.PMID: 2141456 No abstract available.

75) Gamma heavy chain disease associated with Hodgkin’s disease. Clinical, pathologic, and immunologic features of one case.
Di Benedetto G, Cataldi A, Verde A, Gloghini A, Nicolò G, Pistoia V.Cancer. 1989 May 1;63(9):1804-9. doi: 10.1002/1097-0142(19900501)63:9<1804::aid-cncr2820630924>3.0.co;2-8.PMID: 2495168

76) Effect of 17-beta-estradiol on doxorubicin cytotoxicity in human breast cancer cell culture.
Toma S, Leonessa F, Coialbu T, Nicolo G, Rosso R.Anticancer Res. 1989 Mar-Apr;9(2):303-8.PMID: 2751257

77) Lymph node biopsy in the diagnostic and prognostic assessment of patients with HIV infection.
Badellino F, Moresco L, Gipponi M, Cafiero F, Perasole A, Pagano G, Alessandrini A, Nicolò G.Ital J Surg Sci. 1989;19(3):217-24.PMID: 2807838

78) Intrapleural natural beta interferon in the treatment of malignant pleural effusions.
Rosso R, Rimoldi R, Salvati F, De Palma M, Cinquegrana A, Nicolò G, Ardizzoni A, Fusco U, Capaccio A, Centofanti R, et al.Oncology. 1988;45(3):253-6. doi: 10.1159/000226571.PMID: 2453008

79) Immunohistochemical analysis of CEA in colorectal adenomas with and without early cancer.
Gloghini A, Gatteschi MB, Nicolò G.Pathologica. 1987 Jul-Aug;79(1062):437-46.PMID: 3451162 No abstract available.

80) Chemotactic activity “in vitro” and transplantability in isogenic mice of radionuclide-induced murine osteosarcomas.
Aresu O, Allavena G, Melchiori A, Parodi S, D’Amore E, Olivieri GB, Nicolò G, Schmidt J, Albini A.Boll Soc Ital Biol Sper. 1987 May 31;63(5):435-41.PMID: 3477259 No abstract available.

81) A multifactorial analysis of different biological and clinical parameters in breast cancer.
Toma S, Coialbu T, Bonassi S, Nicolò G, Rosso R.Anticancer Res. 1987 May-Jun;7(3 Pt B):401-7.PMID: 3631893

82) [Endometrial adenocarcinoma: relationship between steroid receptors and the degree of cell differentiation].
Marroni P, Barbi GP, Zappa R, Nicolò G, Tanara G, Paganuzzi M, Ferrara GB.Minerva Ginecol. 1987 May;39(5):343-5.PMID: 2819787 Italian. No abstract available.

83) [Breast neoplasms: possible prognostic role of steroid receptors].
Barbi GP, Marroni P, Zappa R, Bruzzi P, Nicolò G, Toma S, Paganuzzi M, Ferrara GB.Minerva Ginecol. 1987 Apr;39(4):225-8.PMID: 3601195 Italian. No abstract available.
84) Correlation between steroid hormone receptors and prognostic factors in human breast cancer.
Barbi GP, Marroni P, Bruzzi P, Nicolò G, Paganuzzi M, Ferrara GB.Oncology. 1987;44(5):265-9. doi: 10.1159/000226492.PMID: 3670793

85) [Latent carcinoma of the prostate. Autopsy study of 100 cases].
Nicolò G, Salvi S, Musso C, d’Amore E.Pathologica. 1986 Sep-Oct;78(1057):579-91.PMID: 3627845 Italian. No abstract available.

86) Primary tumor site, size, patients age and axillary lymph nodes in breast cancers.
Toma S, Bonassi S, Puntoni R, Nicolò G.Tumori. 1986 Jun 30;72(3):259-65. doi: 10.1177/030089168607200306.PMID: 3739006

87) Immunohistochemical detection of carcinoembryonic antigen in infiltrating duct carcinomas of the breast: correlation with morphofunctional parameters and prognostic significance.
d’Amore ES, Gloghini A, Margallo E, Margiocco M, Nicoló G.Arch Anat Cytol Pathol. 1986;34(2):89-94.PMID: 3022656 No abstract available.

88) Antitumoral activity of human fibroblast interferon administered intranodularly.
Rosso R, Nobile MT, Sertoli MR, Giannitelli A, Santi PL, Volpe R, Nicolò G.Oncology. 1985;42(2):86-8. doi: 10.1159/000226006.PMID: 3991108

89) Kaposi’s sarcoma and HTLV-III infection. Virus-like particles in skin lesions: experimental observations.
Cuneo Crovari P, Fusco FA, Ferrarini M, Nicolò G, Rosso R, Crovato F, Scarvaglieri R, Losi E, Mazzoleni C, Crovari P.Boll Ist Sieroter Milan. 1985;64(5):353-62.PMID: 3004541

90) Sampling and storage of breast cancer tissue for steroid receptor assays.
Nicolò G, Carbone A, Esposito M, Santi L.Recent Results Cancer Res. 1984;91:3-11. doi: 10.1007/978-3-642-82188-2_1.PMID: 6729223 No abstract available.

91) Cytology of a breast carcinoma with osteoclastlike giant cells.
Volpe R, Carbone A, Nicolò G, Santi L.Acta Cytol. 1983 Mar-Apr;27(2):184-7.PMID: 6301185 No abstract available.

92) Cytophotometric analysis of the nuclear uptake of adriamycin in in vivo normal mouse liver and kidney cells.
Nicolò G, Esposito M, Belcastro A, Rovida S, Margallo E, Santi L.Anal Quant Cytol. 1982 Dec;4(4):295-301.PMID: 6187255

93) DNA damage in liver of rats treated with nitrofurantoin.
Russo P, Pala M, Nicolò G, Santi L, Parodi S.Mutat Res. 1982 Nov;105(5):377-82. doi: 10.1016/0165-7992(82)90110-5.PMID: 7144796 No abstract available.

94) DNA damage in liver of mice treated with N-nitrodimethylamine.
Pala M, Russo P, Nicolò G, Santi L, Parodi S.Mutat Res. 1982 Mar;103(3-6):207-11. doi: 10.1016/0165-7992(82)90044-6.PMID: 7087987 No abstract available.

95) Positive sputum cytology in hairy cell leukemia.
Volpe R, Carbone A, Casartelli GL, Nicolò G, Santi L.Acta Cytol. 1981 Jul-Aug;25(4):432-4.PMID: 6945012 No abstract available.

96) Value of multiple forceps biopsies in assessing the malignant potential of colonic polyps.
Pugliese V, Gatteschi B, Aste H, Nicolò G, Munizzi F, Giacchero A, Bruzzi P.Tumori. 1981 Feb 28;67(1):57-62. doi: 10.1177/030089168106700111.PMID: 7245356

97) Endoscopy in asymptomatics previously submitted to anterior resection for colorectal cancer.
Aste H, Pugliese V, Nicolò G, Santi L.Cancer Detect Prev. 1981 ;4(1-4):417-20.PMID: 7349804

98) Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients.
Boccardo F, Bruzzi P, Rubagotti A, Nicolò GU, Rosso R.Oncology. 1981 ;38(5):281-5. doi: 10.1159/000225571.PMID: 7266969

99) [Inflammatory carcinoma of the breast (clinical, radiological, pathological and therapeutic correlations)].
Sorice G, Bertoglio C, Nicolò G, Ferrari B.Chir Patol Sper. 1980 Aug;28(4):262-71.PMID: 7307698 Italian. No abstract available.

100)                     Gastric carcinoma: preliminary data of a cooperative program for early diagnosis.
Maltoni G, Pacini F, Moriani M, Amadori D, Ravaioli A, Santi L, Aste H, Nicolò G.Tumori. 1980 Jun 30;66(3):349-56. doi: 10.1177/030089168006600309.PMID: 7445114

101)                     Atrophic gastritis and intestinal metaplasia in asymptomatic Hungarian and Italian populations.
Cheli R, Simon L, Aste H, Figus IA, Nicoló G, Bajtai A, Puntoni R.Endoscopy. 1980 May;12(3):105-8. doi: 10.1055/s-2007-1021722.PMID: 7379759

102)                     [Incidence of atrophic gastritis and intestinal metaplasia in symptomless patients in Hungary and Italy].
Simon L, Figus IA, Bajtai A, Cheli R, Aste U, Nicolo G.Orv Hetil. 1977 Aug 7;118(32):1899-901.PMID: 887260 Hungarian. No abstract available.

103)                     [Whipple’s disease. Digestive bioptic and histochemical findings in a case].
Cheli R, Ramasso M, Nicolò G, Aste H.Minerva Gastroenterol. 1974Apr-Jun;20(2):77-8.PMID: 4138756 Italian. No abstract available.

104)                     [Internal drainage of the thoracic duct in surgical treatment of portal hypertension. 3. Lymphodynamics in experimental ascites after transposition of the thoracic duct].
Donini I, Bresadola F, Anfossi A, Sorice G, Tallero G, Nicolò G.Minerva Chir. 1971 Dec 15;26(23):1327-30.PMID: 5135678 Italian. No abstract available.

105)                     [Internal drainage of the thoracic duct in surgical treatment of portal hypertension. II. Lymphodynamics in experimental ascites].
Donini I, Bresadola F, Anfossi A, Nicolò G, Sorice G, Tallero G, Stabilini L.Minerva Chir. 1971 Dec 15;26(23):1322-6.PMID: 5135677 Italian. No abstract available.
106)                     [Plasmocytoma of the stomach. Anatomo-clinical considerations].
Rossi GN, Nicolò G.Minerva Chir. 1970 Jul 15;25(13):960-70.PMID: 5502115 Italian. No abstract available.

107)                     [Serial experimental study of bilio-digestive anastomoses at various levels and subsequent anatomo-physio-pathological changes. 1. Bilio-jejunal anastomosis].
Berti-Riboli E, Botto A, Costa G, Reboa G, Nicolò G, Arrigo L.Chir Patol Sper. 1970 Apr;18(2):69-81.PMID: 5524706 Italian. No abstract available.

108)                     [Plastic surgery with a serosa patch in lesions of the digestive tract. Experimental research].
Anfossi A, Griffanti Bartoli F, Nicolò G.Chir Patol Sper. 1970 Feb;18(1):1-7.PMID: 5519930 Italian. No abstract available.

109)                     [“Familial” massive hepatic steatosis. Anatomo-clinical considerations].
Nicolò G, Scelsi R.Pathologica. 1970 Jan-Feb;62(905):17-27.PMID: 5523246 Italian. No abstract available.

110)                     [On gastric sarcoma].
Bertolotto E, Nicolò G.Pathologica. 1970 Jan-Feb;62(905):29-36.PMID: 4943096 Italian. No abstract available.

111)                     [A case of primary sarcomatosis of the peritoneal serous membrane].
Nicolò G, Castellaneta A.Pathologica. 1969 Sep-Oct;61(901):333-8.PMID: 5404843 Italian. No abstract available.

112)                     [A case of bronchial fibrolipoma].
Nicolò G, Castellaneta A.Pathologica. 1969 Sep-Oct;61(901):329-32.PMID: 5404842 Italian. No abstract available.

113)                     [Adenomatoid tumor of epididymis. 2 personal cases].
Nicolò G, Castellaneta A.Pathologica. 1969 Sep-Oct;61(901):317-27.PMID: 5404841 Italian. No abstract available.

114)                     [Another case of circumscribed folds hyperplasia of the gastric mucosa].
Castellaneta A, Nicolò G.Pathologica. 1969 Sep-Oct;61(901):311-5.PMID: 5404840 Italian. No abstract available.

115)                     [So-called cystosarcoma phyllodes of the breast].
Canepa M, Nicoló G.Pathologica. 1967 Nov-Dec;59(879):367-75.PMID: 4319298 Italian. No abstract available.

Indice Focus

INDICE H-INDEX

L’indice H (H-index) per un ricercatore di nome Guido Nicolò, che sembra essere attivo nel campo della ricerca biomedica/oncologica, varia a seconda della banca dati utilizzata (Google Scholar o Scopus).

Secondo un documento che elenca le sue pubblicazioni scientifiche:

H-index su Scopus: 59.
H-index su Google Scholar: 66.

Questi dati si basano su un curriculum vitae che copre le pubblicazioni fino ad almeno il 2018, con oltre 17.000 citazioni su Scopus e oltre 24.000 su Scholar al momento della stesura del documento